Project description
Digitalisation of the ankle-foot orthosis design and manufacturing
An ankle-foot orthosis (AFO) helps patients who suffer from neuromuscular disorders resulting in gait disabilities such as the foot drop syndrome. Presently, adapted orthosis manufacturing is a manual procedure associated with a long and expensive process, highly dependent on the orthopaedist's expertise. The EU-funded MOWA will develop an AFO with innovative design and production process, applying Big Data and machine learning for fast and cost-efficient production. MOWA development will rely on the digitalisation of the design and manufacturing where each component is individually produced and fits patients’ anatomy, optimally supporting their walking. Additionally, the AFO could be easily reproduced, which is relevant for children who often need orthosis replacement.
Objective
By 2020, up to 23 million EU citizens will suffer from a neuromuscular disorder resulting in gait disabilities such as the foot drop syndrome, a condition that causes patients often stumbling and even falling. Ankle foot orthoses (AFO) are widely used to help these patients. The objective is to fully support or restore patient’s mobility, so the orthosis must be designed to match patients’ anatomy and therapeutic needs, a constantly changing pattern in most of the patients with neuromuscular diseases. Nowadays, the manufacture of adapted orthoses is still a manual procedure highly dependent on the orthopaedist expertise, resulting in a long and expensive process, often traumatic for patients, especially children. With the aim of offering to our neuro- orthopaedic patients the best treatment and support during the mobility recovery therapy, we have developed MOWA, an innovative ankle-food-orthosis (AFO) with an associated design and production process fully digitalised that fully exploits the benefits of big data and machine learning enabling a fast and cost-efficient production of customised orthoses. MOWA uniqueness relies on the digitalisation of the design and manufacture steps so that each component is individually produced, thus the orthosis perfectly fits patients’ anatomy and optimally supports their walking. In addition, the orthosis can be easily reproduced, something especially relevant for children, who need to replace their orthosis twice a year so that it grows with them. Custom-made orthoses will play a key role within the global orthotics market, which was valued at €2,750 million in 2016, and is projected to grow at a CAGR=5.8% until 2023. MOWA’s Total Addressable Market in 2020 is expected to surpass the 320,000 units, with an associate value of €256 million. In addition, MOWA will boost the growth of our company with revenues surpassing the €20 million in the 3rd year after market uptake and the creation of up to 20 new positions.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine anatomy and morphology
- natural sciences computer and information sciences data science big data
- medical and health sciences clinical medicine psychiatry anxiety disorders
- medical and health sciences basic medicine neurology
- natural sciences computer and information sciences artificial intelligence machine learning
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
4500 SOLOTHURN
Switzerland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.